Lynx1 Capital Management LP

10% owner at TScan Therapeutics, Inc. · on record since Jun 2, 2023
10% owner at Passage BIO, Inc. · on record since Aug 9, 2024
10% owner at Cullinan Therapeutics, Inc. · on record since Oct 30, 2025
10% owner at Neuphoria Therapeutics Inc. · on record since Oct 23, 2025
10% owner at Korro Bio, Inc. · on record since Apr 2, 2026

Insider trading activity of Lynx1 Capital Management LP

Transactions on record: 28; since Jun 2, 2023

Open-market buys: 24; $20M

Open-market sells: 3; $63.9K

Companies traded: 5; last filing Aug 13, 2026

Figures computed from official regulatory filings — .

Companies where Lynx1 Capital Management LP has traded

Korro Bio, Inc.3 tx · $84.3K · Aug 13, 2026
Passage BIO, Inc.8 tx · $1.5M · Jun 29, 2026
TScan Therapeutics, Inc.9 tx · $39M · Dec 23, 2025
Neuphoria Therapeutics Inc.1 tx · $3.3M · Oct 23, 2025
Cullinan Therapeutics, Inc.7 tx · $11.9M · Oct 21, 2025

Track record of Lynx1 Capital Management LP

Statistical track record

Free account

Open-market buys: 25

Last buy: Aug 10, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Lynx1 Capital Management LP

Co-insiders of Lynx1 Capital Management LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Aug 13, 2026	Buy	5,222	11.40 USD	$59.5K	conv 19	SEC
Korro Bio, Inc.Listing on record	Aug 13, 2026	Buy	1,462	13.19 USD	$19.3K	conv 17	SEC
Passage BIO, Inc.Listing on record	Jun 29, 2026	Buy	50,055	4.12 USD	$206.1K	conv 34	SEC
Korro Bio, Inc.Listing on record	Apr 2, 2026	Buy	520	10.60 USD	$5.5K	conv 32Cluster	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	75,500	0.90 USD	$68K	conv 29	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	80,069	0.90 USD	$72.1K	conv 31	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	6,232	0.90 USD	$5.6K	conv 29	SEC
Neuphoria Therapeutics Inc.Listing on record	Oct 23, 2025	Buy	639,110	5.14 USD	$3.3M	conv 53	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	15,032	7.59 USD	$114.1K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	150,000	8.86 USD	$1.3M	conv 18	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	51,500	7.94 USD	$408.9K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	32,217	7.84 USD	$252.6K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	556,300	6.46 USD	$3.6M	conv 34	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	626,043	6.70 USD	$4.2M	conv 32	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	277,298	7.36 USD	$2M	conv 30	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	13,123	5.44 USD	$71.4K	conv 32	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	49,302	5.74 USD	$283K	conv 32	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	66,423	5.71 USD	$379.3K	conv 33	SEC
TScan Therapeutics, Inc.Listing on record	May 21, 2025	Buy	1,200,000	1.20 USD	$1.4M	conv 34	SEC
TScan Therapeutics, Inc.Listing on record	May 21, 2025	Buy	1,388,794	1.20 USD	$1.7M	conv 41	SEC
Passage BIO, Inc.Listing on record	Dec 31, 2024	Buy	373,645	0.65 USD	$242.9K	conv 31	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	259,998	0.56 USD	$145.6K	conv 47	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	167,055	0.71 USD	$118.6K	conv 23	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	29,300	0.67 USD	$19.6K	conv 29	SEC
TScan Therapeutics, Inc.Listing on record	Apr 23, 2024	BuyD (derivative)	5,000,000	7.13 USD	$35.7M	First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Aug 13, 2026	Buy	5,222	11.40 USD	$59.5K	conv 19	SEC
Korro Bio, Inc.Listing on record	Aug 13, 2026	Buy	1,462	13.19 USD	$19.3K	conv 17	SEC
Passage BIO, Inc.Listing on record	Jun 29, 2026	Buy	50,055	4.12 USD	$206.1K	conv 34	SEC
Korro Bio, Inc.Listing on record	Apr 2, 2026	Buy	520	10.60 USD	$5.5K	conv 32Cluster	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	75,500	0.90 USD	$68K	conv 29	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	80,069	0.90 USD	$72.1K	conv 31	SEC
TScan Therapeutics, Inc.Listing on record	Dec 23, 2025	Buy	6,232	0.90 USD	$5.6K	conv 29	SEC
Neuphoria Therapeutics Inc.Listing on record	Oct 23, 2025	Buy	639,110	5.14 USD	$3.3M	conv 53	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	15,032	7.59 USD	$114.1K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	150,000	8.86 USD	$1.3M	conv 18	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	51,500	7.94 USD	$408.9K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 21, 2025	Buy	32,217	7.84 USD	$252.6K	conv 17	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	556,300	6.46 USD	$3.6M	conv 34	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	626,043	6.70 USD	$4.2M	conv 32	SEC
Cullinan Therapeutics, Inc.Listing on record	Oct 10, 2025	Buy	277,298	7.36 USD	$2M	conv 30	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	13,123	5.44 USD	$71.4K	conv 32	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	49,302	5.74 USD	$283K	conv 32	SEC
Passage BIO, Inc.Listing on record	Jul 24, 2025	Buy	66,423	5.71 USD	$379.3K	conv 33	SEC
TScan Therapeutics, Inc.Listing on record	May 21, 2025	Buy	1,200,000	1.20 USD	$1.4M	conv 34	SEC
TScan Therapeutics, Inc.Listing on record	May 21, 2025	Buy	1,388,794	1.20 USD	$1.7M	conv 41	SEC
Passage BIO, Inc.Listing on record	Dec 31, 2024	Buy	373,645	0.65 USD	$242.9K	conv 31	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	259,998	0.56 USD	$145.6K	conv 47	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	167,055	0.71 USD	$118.6K	conv 23	SEC
Passage BIO, Inc.Listing on record	Nov 27, 2024	Buy	29,300	0.67 USD	$19.6K	conv 29	SEC
TScan Therapeutics, Inc.Listing on record	Apr 23, 2024	BuyD (derivative)	5,000,000	7.13 USD	$35.7M	First in 12mo	SEC